Overproduction of IFN-γ and TNF-α from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 917, Issue , 2000, Pages 331-340

  Solerte, S B ^a   Cravello, L ^a   Ferrari, E ^a   Fioravanti, M ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALZHEIMER DISEASE; CELL FUNCTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; GENE OVEREXPRESSION; HUMAN; MALE; NATURAL KILLER CELL; NERVE DEGENERATION; NEUROIMMUNOLOGY;

EID: 0033664955     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05399.x     Document Type: Conference Paper

References (38)

1. Neuroimmunology of Alzheimer's disease: A conference report
2. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy
3. Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage
4. Neuroimmune mechanisms in Alzheimer's disease pathogenesis
5. Neuroautoimmunity: Pathogenetic implications for Alzheimer's disease
6. Heterogeneity of natural killer cells
7. Biology of natural killer cells
8. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
9. Enhanced cytotoxic response of natural killer cells to IL-2 in Alzheimer's disease
10. Excitatory pattern of γ-interferon on natural killer cell activity in senile dementia of the Alzheimer type
11. Variability of natural killer (NK) cell immune function in normal aging and senile dementia: Pathophysiological implications
12. Decreased immunosuppressive effect of cortisol on natural killer cytotoxic activity in senile dementia of the Alzheimer's type
13. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation
14. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type
15. Pivotal role of endogenous TNF-α in the IL-2 driven activation and proliferation of the functionally immune NK 'free' subset
16. Brain microvascular changes in Alzheimer's disease and other dementias
17. TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs
18. Amyloid-β induces chemokine secretion and monocyte migration across a bloodbrain barrier model
19. Enhanced expression of the bloodbrain barrier GLUT1 glucose transporter gene by brain-derived factors
20. Cytokines in the central nervous system: Regulatory roles in neuronal function, cell death and repair
21. Admission criteria for immunogerontological studies in man: The SENIEUR protocol
22. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
23. Multiinfarct dementia: A cause of mental deterioration in the elderly
24. Apolipoprotein E genotyping by one-stage PCR
25. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician
26. An enzyme-release assay for natural cytotoxicity
27. Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells. A short review
28. Transmembrane signaling during natural killer cell-mediated cytotoxicity. Regulation by protein kinase C activation
29. Production of hematopoietic colony-stimulating factor by human natural killer cells
30. Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α
31. The role of tumor necrosis factor, interleukin 6, interferon-γ and inducible nitric oxide synthase in the development and pathology of the nervous system
32. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease
33. Hemorheologic changes and overproduction of cytokines in mild to moderate dementia of the Alzheimer's type: Adverse effects on cerebrovascular system and therapeutic approach with pentoxifylline
34. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging
35. Reduced glucose transporter at the blood-brain barrier in cerebral cortex in Alzheimer's disease
36. Altered glucose metabolism in microvessels from patients with Alzheimer's disease
37. Mitochondrial genome lesions in the pathogenesis of sporadic Alzheimer's disease